Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Spinout Syntopix announces new funding deal

28.10.2004


University of Leeds life sciences company Syntopix Ltd has secured further capital of just under £180,000 through a consortium of regional investors.

Formed in 2003, Syntopix is based on the leading research of husband and wife team Drs Jon Cove and Anne Eady, both microbiologists in the University’s Skin Research Centre. Their work focuses on developing novel therapeutics for dermatological diseases, including acne and Staphylococcus aureus infections such as the ‘superbug’ MRSA.

The deal, announced this week, sees investment from a consortium comprising: Techtran Group Ltd, regional venture capital funds the White Rose Technology Seedcorn Fund and the Viking Fund, and business angels Dr Gwyn Humphreys and Dr Rod Adams.



Dr Humphreys has been appointed as the company’s new chairman and Dr Adams joins Syntopix as a non-executive director. Both have successful track records in growing businesses in the pharmaceutical industry. Dr Humphreys was joint founder / CEO of Bradford Particle Design, sold to Inhale Therapeutics in 2001 for $200m and Dr Adams was formerly CEO of Medical Solutions plc and local dermatology company Adams Healthcare. Dr Alex Stevenson has joined the company as Chief Executive Officer.

Syntopix was spun out by Techtran Group, the commercialisation partner of the University of Leeds, and the science underpinning the company was initially funded with £500,000 from the Wellcome Trust. The company’s approach is to generate new therapeutic products for target diseases by identifying novel combinations of compounds which together deliver new therapeutic benefits. Since the majority of the compounds used already have well-documented pharmacology and toxicity profiles and are already established as safe for human use, the development cycle of new products can be substantially reduced, saving both time and money. The company is rapidly developing a pipeline of its own drug candidates, and expects to commence clinical trials of its lead candidates in the next two to three years.

In addition the company offers contract testing and expert consultancy in pre-clinical and clinical drug development. A number of contracts with partners in the dermatology arena are already in place. The new funding strengthens the management structure, increases the research team to six and will accelerate the development of anti-acne products.

Syntopix CEO Dr Alex Stevenson said: “We are delighted to have received the backing of such a broad range of regional investors and look forward to bringing the results of our research to the clinic.”

The White Rose Technology Seedcorn Fund has to date invested in nineteen spinout companies from the Universities of Leeds, Sheffield and York. Investment Manager, Dr Susan Hill, said: “We were attracted to Syntopix’ considerable expertise in the field of skin diseases, which includes a number of significant markets, and the company’s approach to product development. We look forward to working with the team to deliver on its exciting potential.”

The investment is the first for the Viking Fund, which was established in June to provide seed capital for technology-based early stage companies in the Yorkshire and Humber region. Viking Fund managing director Andrew Burton said: “Syntopix is fairly typical of early-stage, technology businesses in which Viking Fund is looking to invest. It has high quality science, a simple commercial model, experienced people and ready matching investment.”

Dr Alex Stevenson | alfa
Further information:
http://www.syntopix.com

More articles from Life Sciences:

nachricht New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences

nachricht The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>